Methods: Stage1: a clinical trial study conducted in 174 pregnant women having threatened preterm labor at 30 - 34 weeks with singleton pregnancies and without fetal anomalies at Hung vuong hospital, HCMC from 01/12/2004 to 01/05/2006.